Current Suspected Overdose Deaths in Delaware for 2024: Get Help Now!
Find school water testing results and additional resources
Attention Medicaid Participants: Eligibility Renewals Restarted April 1, 2023
The Delaware Division of Public Health wishes to alert the Delaware medical community about an increase in syphilis cases among men who have sex with men (MSM).
Delaware has also seen an increase in primary and secondary syphilis cases. The 20 reported cases for 2006 represents a twofold increase compared to 2005 (11). Fifteen of the cases diagnosed in 2006 are male cases and 11 of those are MSM.
These facts serve as a reminder that the following information from the 2006 STD Treatment Guidelines should be considered when diagnosing and managing all cases of syphilis and their contacts.
Patients who are infected with syphilis may seek treatment for the signs or symptoms of primary infection such as an ulcer or chancre at the infection site, or secondary infection manifestations that include, but are not limited to, unexplained skin rash, mucocutaneous lesions (including but are not limited to, genital, anogenital, or oral lesions) and lymphadenopathy.
Persons exposed sexually to a patient who has syphilis in any stage should be evaluated clinically and serologically and treated with a recommended regimen, according to the following recommendations:
This information is extracted from the 2006 CDC STD Treatment Guidelines
STAGE OF DISEASE | RECOMMENDED TREATMENT | ALTERNATIVES |
---|---|---|
PRIMARY, SECONDARY OR EARLY LATENT (< 1 YEAR) |
Adults:
|
See CDC Treatment Guidelines |
LATE LATENT (> 1 YEAR) OR LATENT OF UNKNOWN DURATION |
Adults:
|
See CDC Treatment Guidelines |
PREGNANCY | Penicillin is the only recommended treatment for syphilis during pregnancy. Women who are allergic should be desensitized and then treated with penicillin. Dosages are the same as in non-pregnant patients for each stage of syphilis. Erythromycin has an unacceptable failure rate to cure the infected fetus and is therefore not recommended. | See CDC Treatment Guidelines |
For additional information, you may contact the Division of Public Health Sexually Transmitted Disease Program office at (302) 741-2920.